Page last updated: 2024-09-05

lu 135252 and Polycystic Kidney Diseases

lu 135252 has been researched along with Polycystic Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arck, PC; Godes, M; Herzfeld, S; Hocher, B; Kalk, P; Mach, A; Nafz, B; Neumayer, HH; Slowinski, T; Wiesner, D	1

Other Studies

1 other study(ies) available for lu 135252 and Polycystic Kidney Diseases

Article	Year
ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:2 Topics: Animals; Disease Progression; Endothelin Receptor Antagonists; Fibrosis; Kidney; Kidney Tubules; Male; Organ Size; Phenylpropionates; Polycystic Kidney Diseases; Propionates; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renal Circulation	2003

Article

Year

ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.

Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:2

Topics: Animals; Disease Progression; Endothelin Receptor Antagonists; Fibrosis; Kidney; Kidney Tubules; Male; Organ Size; Phenylpropionates; Polycystic Kidney Diseases; Propionates; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renal Circulation

2003